Fig. 2From: Stage-associated differences in the serum N- and O-glycan profiles of patients with non-small cell lung cancerLectins revealed significant differences among Stage I/II, Stage III, and Stage IV adenocarcinoma groups according to ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001Back to article page